Hostname: page-component-77c89778f8-sh8wx Total loading time: 0 Render date: 2024-07-17T23:52:51.475Z Has data issue: false hasContentIssue false

Neosartorya hiratsukae: Environmental isolation from intensive care units in an Italian hospital

Published online by Cambridge University Press:  09 June 2021

Anna Prigitano*
Affiliation:
Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy
Maria C. Esposto
Affiliation:
Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy
Davide Carnevali
Affiliation:
Postgraduate School in Public Health, Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy
Emanuele Catena
Affiliation:
Department of Anaesthesiology and Intensive Care Unit, Luigi Sacco Hospital, Milano, Italy
Francesco Auxilia
Affiliation:
Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy ASST Fatebenefratelli Sacco, Milano, Italy
Silvana Castaldi
Affiliation:
Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Italy
Luisa Romanò
Affiliation:
Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy
*
Author for correspondence: Dr Anna Prigitano, E-mail: anna.prigitano@unimi.it
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

To the Editor—Fungi are opportunistic pathogens, ubiquitously distributed. Fungal colonization acquired from the environment might evolve into an invasive infection during hospitalization due to immunosuppressive treatments to which patients are exposed. Environmental surveillance in hospital settings requires special attention to prevent fungal and non-fungal infections. Invasive aspergillosis is one of the most important infections caused by Aspergillus. Neosartorya hiratsukae, teleomorph of the Aspergillus section Fumigati, is a rare fungus isolated for the first time in Japan from indoor air and from pasteurized aloe juice. Reference Udagawa, Tsubouchi and Horie1

Neosartorya hiratsukae is an opportunistic pathogen and only few cases of human infections have been reported worldwide. Reference Guarro, Kallas and Godoy2Reference Koutroutsos, Arabatzis, Bougatsos, Xanthaki, Toutouza and Velegraki6 N. hiratsukae is often misidentified because it cannot be distinguished from A. fumigatus sensu stricto by conventional morphological macroscopic and microscopic analyses or by the extensively used matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). However, rapid and accurate identification is important for therapeutic purposes due to the different patterns of susceptibility to antifungal drugs.

In this study, we investigated the environmental isolation of N. hiratsukae from 2 different intensive care units (ICUs) in a hospital in Milan, Italy. In January 2020, environmental sampling was conduted using contact plates as part of an environmental surveillance study. In total, 9 bed stations and 2 medical stations were sampled, for a total of 55 samples. After macroscopic and microscopic analyses, identification was confirmed by molecular analysis. Antifungal susceptibility testing was performed by broth microdilution assay according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) to determine the minimum inhibitory concentration (MIC). Reference Rodriguez-Tudela, Arendrup and Arikan7 The following antifungals were tested: itraconazole, voriconazole, posaconazole, isavuconazole and amphotericin B (Sigma-Aldrich, St Louis, MO).

Fungi grew from 18.2% of the environmental samples; molds grew from 8 samples. We identified 2 mold colonies, isolated from a cooling fan and from the handles of a patient bed, as A. niger and A. fumigatus. In total, 13 colonies of filamentous fungi isolated from 6 samples showed slow growth, with restricted white colonies and light-brown reverse. In particular, in one ICU, 12 colonies grew from the scialytic lamps (n = 7) of 2 different patient beds, from the computer keyboard of the medical station (n = 3), from the patient vital signs monitor (n = 1) and from the bed handles (n = 1). The last colony was isolated from the printer of the medical station of the other ICU. The microscopic examination of these colonies revealed A. fumigatus–like conidial head, a large number of cleistothecia, and hyaline, lenticular ascospores with equatorial crests. The β-tubulin sequences analysis showed a 100% homology with the reference sequence of N. hiratsukae (sequence AF057324).

Neosartorya hiratsukae antifungal susceptibility testing yielded the following MIC values: itraconazole, 0.12 mg/L; voriconazole, 0.03 mg/L; posaconazole, 0.06 mg/L; isavuconazole, 0.12 mg/L; and amphotericin B, <0.03 mg/L. No break points (BPs) have been specified for N. hiratsukae; however, the MIC values of our isolate are low and under the EUCAST BPs established for A. fumigatus. 8

No cases of aspergillosis were diagnosed in the 2 ICUs in a 5-month period, 3 before the isolation of N. hiratsukae from the environment and 2 thereafter (Dr R. Grande, personal communication). In July 2020, we were able to perform further environmental samplings, but neither N. hiratsukae nor other fungi were isolated.

Like all filamentous fungi, Neosartorya also has an environmental origin. In the literature, N. hiratsukae has been reported in the indoor air Reference Udagawa, Tsubouchi and Horie1 and on drywall, where the small white colonies are hardly visible, so the spores can easily spread in the environment causing a health risk. Reference Andersen, Dosen, Lewinska and Nielsen9 In the 2 ICUs examined, no renovations had been made in the period prior to the sampling, and there is no drywall in these wards. However, the presence of this material in other wards or hospital common areas is not excluded. The presence of N. hiratsukae on the computer keyboard and printer in the medical stations suggests that it may have been spread by healthcare professionals.

Unfortunately, the rapid evolution of the COVID-19 epidemic in Italy shortly after our environmental sampling prevented further control samplings until 6 months later, when no N. hiratsukae were isolated. A more accurate sanitation during COVID-19 epidemic has probably reduced the presence of possible pathogens on the surfaces.

Despite the presence of N. hiratsukae in the environment of the sampled ICUs, no clinical isolates of N. hiratsukae were detected in the hospital in the same period, even if it cannot be ruled out due to the difficulties in identifying this species. Indeed, macroscopic and microscopic identification is not specific, and methods such as MALDI, in use in the hospital microbiology laboratories, do not identify this species. Neosartorya infections are probably underreported due to the aforementioned difficulties in identification and to the laboratory practice of discarding the nonsporulating or slowly sporulating white mycelia as laboratory contaminants.

Variable MIC values for N. hiratsukae are reported in the literature, showing mainly azole-susceptible patterns Reference Guarro, Kallas and Godoy2,Reference Mellado, Alcazar-Fuoli, Garcia-Effron, Alastruey-Izquierdo, Cuenca-Estrelal and Rodriguez-Tudela5,Reference Koutroutsos, Arabatzis, Bougatsos, Xanthaki, Toutouza and Velegraki6 and some sporadic high itraconazole MIC values. Reference Koutroutsos, Arabatzis, Bougatsos, Xanthaki, Toutouza and Velegraki6

Preventing nosocomial infections is very important, especially for ICU patients. Environmental control through environmental sampling of air and surfaces represents a valid tool that should be performed systematically, not only in the case of an outbreak. Laboratory routine methods for the identification are not sufficient to perform the correct identification of N. hiratsukae, obtainable only with molecular biology techniques. The correct identification of N. hiratsukae and other Neosartorya spp as well as their antifungal susceptibilities should be further investigated.

Acknowledgments

The authors would like to thank Dr Romualdo Grande for his communication and the hospital staff of the ICU involved in this study for their collaboration.

Financial support

No financial support was provided relevant to this article.

Conflicts of interest

All authors report no conflicts of interest relevant to this article.

Footnotes

a

Authors of equal contribution.

References

Udagawa, S, Tsubouchi, H, Horie, Y. Neosartorya hiratsukae, a new species of food-borne Ascomycetes. Trans Mycol Soc Jpn 1991;32:2329.Google Scholar
Guarro, J, Kallas, EG, Godoy, P, et al. Cerebral aspergillosis caused by Neosartorya hiratsukae, Brazil. Emerg Infect Dis 2002;8:989991.CrossRefGoogle ScholarPubMed
Predari, SC, de Paulis, AN, Veron, D, Zucchini, A, Santoianni, JE. Fungal peritonitis in patients on peritoneal dialysis: twenty-five years of experience in a teaching hospital in Argentina. Rev Argent Microbiol 2007;39:213217.Google Scholar
Shivaprakash, MR, Jain, N, Gupta, S, Baghela, A, Gupta, A, Chakrabarti, A. Allergic fungal rhinosinusitis caused by Neosartorya hiratsukae from India. Med Mycol 2009;47:317320.CrossRefGoogle ScholarPubMed
Mellado, E, Alcazar-Fuoli, L, Garcia-Effron, G, Alastruey-Izquierdo, A, Cuenca-Estrelal, M, Rodriguez-Tudela, JL. New resistance mechanisms to azole drugs in Aspergillus fumigatus and emergence of antifungal drugs-resistant A. fumigatus atypical strains. Med Mycol 2006;44:S367S371.CrossRefGoogle ScholarPubMed
Koutroutsos, K, Arabatzis, M, Bougatsos, G, Xanthaki, A, Toutouza, M, Velegraki, A. Neosartorya hiratsukae peritonitis through continuous ambulatory peritoneal dialysis. J Med Microbiol 2010;59:862865.CrossRefGoogle ScholarPubMed
Rodriguez-Tudela, JL, Arendrup, MC, Arikan, S, et al. European Committee on Antimicrobial Susceptibility Testing. EUCAST definitive document E.DEF 9.1: Method for Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal Agents for Conidia-Forming Moulds. Växjö, Sweden: EUCAST; 2008.Google Scholar
Antifungal agents’ breakpoint tables for interpretation of MICs—version 10.0. European Committee on Antimicrobial Susceptibility Testing website. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Clinical_breakpoints/AFST_BP_v10.0_200204.pdf. Accessed March 25, 2021.Google Scholar
Andersen, B, Dosen, I, Lewinska, AM, Nielsen, KF. Pre-contamination of new gypsum wallboard with potentially harmful fungal species. Indoor Air 2017;27:612.CrossRefGoogle ScholarPubMed